Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative bevacizumab + capecitabine + radiotherapy with or without oxaliplatin in locally advanced rectal cancer
2007-007177-23Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Sep 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of bevacizumab in rectal cancer and locally advanced rectal cancer (LARC) (2 arms), sponsored by UZ Leuven. Primary endpoint: Pathologic complete response rate. Started Sep 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancerlocally advanced rectal cancer (LARC)
Beyond the preview
Go deeper on 2007-007177-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007177-23.